These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8285286)

  • 1. Biological actions of brain natriuretic peptide in thoracic inferior vena caval constriction.
    Clavell AL; Stingo AJ; Aarhus LL; Burnett JC
    Am J Physiol; 1993 Dec; 265(6 Pt 2):R1416-22. PubMed ID: 8285286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure.
    Grantham JA; Borgeson DD; Burnett JC
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1077-83. PubMed ID: 9140004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of renal response to atrial natriuretic factor in experimental low-output heart failure.
    Redfield MM; Edwards BS; Heublein DM; Burnett JC
    Am J Physiol; 1989 Oct; 257(4 Pt 2):R917-23. PubMed ID: 2529785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and renal actions of C-type natriuretic peptide.
    Stingo AJ; Clavell AL; Aarhus LL; Burnett JC
    Am J Physiol; 1992 Jan; 262(1 Pt 2):H308-12. PubMed ID: 1310235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endogenous atrial natriuretic factor in acute congestive heart failure.
    Lee ME; Miller WL; Edwards BS; Burnett JC
    J Clin Invest; 1989 Dec; 84(6):1962-6. PubMed ID: 2531762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention.
    La Villa G; Riccardi D; Lazzeri C; Casini Raggi V; Dello Sbarba A; Tosti Guerra C; Fronzaroli C; Foschi M; Laffi G; Gentilini P
    Hepatology; 1995 Dec; 22(6):1745-50. PubMed ID: 7489983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proximal tubular function in dogs with thoracic caval constriction.
    Auld RB; Alexander EA; Levinsky NG
    J Clin Invest; 1971 Oct; 50(10):2150-8. PubMed ID: 5116206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
    Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin in thoracic inferior vena caval constriction model of heart failure.
    Underwood RD; Aarhus LL; Heublein DM; Burnett JC
    Am J Physiol; 1992 Sep; 263(3 Pt 2):H951-5. PubMed ID: 1415622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological features of edematous dogs unresponsive to atrial natriuretic peptide.
    Maher E; Cernacek P; Levy M
    Am J Physiol; 1990 Jun; 258(6 Pt 2):F1490-6. PubMed ID: 2163212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
    Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
    J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
    Chen HH; Lainchbury JG; Matsuda Y; Harty GJ; Burnett JC
    Hypertension; 2001 Aug; 38(2):187-91. PubMed ID: 11509474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated renal excretory response to atrial natriuretic peptide in congestive heart failure in man.
    Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Pedersen EB
    Int J Cardiol; 1991 Oct; 33(1):61-74. PubMed ID: 1657800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute volume expansion and altered hemodynamics on renal tubular function in chronic caval dogs.
    Levy M
    J Clin Invest; 1972 Apr; 51(4):922-38. PubMed ID: 5014619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal role of the endogenous natriuretic peptide system in acute congestive heart failure.
    Stevens TL; Rasmussen TE; Wei CM; Kinoshita M; Matsuda Y; Burnett JC
    J Card Fail; 1996 Jun; 2(2):119-25. PubMed ID: 8798113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.
    Ichiki T; Huntley BK; Sangaralingham SJ; Burnett JC
    JACC Heart Fail; 2015 Sep; 3(9):715-23. PubMed ID: 26362447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximizing the natriuretic peptide system in experimental heart failure: subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition.
    Chen HH; Lainchbury JG; Harty GJ; Burnett JC
    Circulation; 2002 Feb; 105(8):999-1003. PubMed ID: 11864932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal blockade to angiotensin II in acute and chronic sodium-retaining states.
    Slick GL; DiBona GF; Kaloyanides GJ
    J Pharmacol Exp Ther; 1975 Nov; 195(2):185-93. PubMed ID: 1185590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.